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Abstract
Streptococcus agalactiae causes urinary tract infection (UTI) in pregnant adults, non-preg-
nant adults, immune-compromised individuals and the elderly. The pathogenesis of S. aga-
lactiae UTI in distinct patient populations is poorly understood. In this study, we used murine
models of UTI incorporating young mice, aged and dam mice to show that uropathogenic
S. agalactiae causes bacteriuria at significantly higher levels in aged mice compared to
young mice and this occurs coincident with equivalent levels of bladder tissue colonisation
at 24 h post-infection (p.i.). In addition, aged mice exhibited significantly higher bacteriuria
burdens at 48 h compared to young mice, confirming a divergent pattern of bacterial coloni-
zation in the urinary tract of aged and young mice. Multiparous mice, in contrast, exhibited
significantly lower urinary titres of S. agalactiae compared to age-matched nulliparous mice
suggesting that parity enhances the ability of the host to control S. agalactiae bacteriuria.
Additionally, we show that both age and parity alter the expression levels of several key reg-
ulatory and pro-inflammatory cytokines, which are known to be important the immune
response to UTI, including Interleukin (IL)-1β, IL-12(p40), and Monocyte Chemoattractant
Protein-1 (MCP-1). Finally, we demonstrate that other cytokines, including IL-17 are induced
significantly in the S. agalactiae-infected bladder regardless of age and parity status. Collec-
tively, these findings show that the host environment plays an important role in influencing
the severity of S. agalactiae UTI; infection dynamics, particularly in the context of bacteri-
uria, depend on age and parity, which also affect the nature of innate immune responses to
infection.
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Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting 150
million people each year worldwide [1]. UTIs are especially prevalent in women; one-third of
all women will have experienced a UTI by the age of twenty-four and, with a risk of recurrent
infection approaching 30% [2, 3], these infections account for a massive economic cost to the
health care sector. Each infectious episode causes serious deterioration in the quality of life [4].
The majority of UTIs (~80%) are caused by Escherichia coli. A range of other bacteria includ-
ing Streptococcus agalactiae can also efficiently colonise the genitourinary tract and cause vari-
ous conditions resulting from UTI including cystitis, pyelonephritis and asymptomatic
bacteriuria (ABU) [5–7]. S. agalactiae bacteriuria is especially important in pregnant women
because infection has been associated with chorioamnionitis [8] and because of the potential
for vertical transmission and neonatal disease [9]. Overall, the burden of S. agalactiae UTI in
the United States is approximately 160,000 cases annually [7, 10]. Several studies have demon-
strated that the pathogenesis of S. agalactiae UTI encompasses binding of the bacteria to the
bladder [11, 12], cytotoxicity in urothelial cells, and elicitation of pro- and anti-inflammatory
cytokine and chemokine responses [13, 14], as well as growth of some ABU-causing S. agalac-
tiae in human urine that may affect persistence [15].
While globally it is estimated that S. agalactiae is associated with 2–3% of all UTIs [16, 17],
the incidence of infection appears to differ among distinct patient populations such as healthy
adults, pregnant women, and institutionalized elderly individuals [10, 18]. Reported preva-
lence rates of S. agalactiae ABU and UTI of 26% and 39% among diabetic gravidas women
[19] and nursing home residents >70 years of age [20], respectively, for example, compare to
rates of below 5.5% reported among healthy adult women [18]. These broad differences in S.
agalactiae prevalence rates among distinct patient groups reported in epidemiological studies
of UTI might reflect distinct elements of host susceptibility and pathogenesis in dissimilar host
environments; prior studies, for example, have demonstrated pathogen-specific host responses
[12] and immune modulation during S. agalactiae UTI [21] using experimental infection of
mice to model human UTI [22]. Additionally, a multitude of recent studies have described
host-driven determinants of the severity of UTI due to E. coli, as reviewed elsewhere [23].
However, the role of diverse host environments in affecting the pathogenesis of S. agalactiae
UTI remains largely understudied. In this context, one recent study examined age and parity
in S. agalactiae UTI and reported that parity increases bacterial colonisation of the bladder in
multiparous mice compared to nulliparous mice [24]. S. agalactiae bladder colonisation in
mice, reported in [24], was also found to be higher in young mice (8–10 weeks) compared to
aged mice (7–11 months) [24], implying that younger age may predispose to S. agalactiae UTI;
however, the study did not analyse cytokine responses nor assess levels of bacteriuria in the
model.
Here, we sought to compare the dynamics of infection during S. agalactiae UTI using
murine models incorporating distinct groups of mice to model states of young and old age,
and nulliparous vs. multiparous backgrounds. We examined infection in the bladder, as
reported previously [24], and bacteriuria and inflammatory mediators in the bladder that
might influence UTI, but which have not been examined previously.
Materials and Methods
Bacteria
The serotype III uropathogenic S. agalactiae (UPSA) strain (0247) used in this study was previ-
ously described [12]. Briefly, the UPSA 0247 strain was originally cultured from clean-catch
Effect of Age and Parity on S. agalactiae UTI
PLOS ONE | DOI:10.1371/journal.pone.0167732 December 9, 2016 2 / 16
Peter Doherty Fellowship (APP1052464). GCU is
supported by a Australian Research Council Future
Fellowship (FT110101048). The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
voided urine of a 35-year-old non-diabetic woman who presented to the University of Ala-
bama Birmingham (UAB) Hospital with symptoms consistent with uncomplicated cystitis,
including dysuria, single organism bacteriuria (>100,000 colony forming units [cfu] ml-1),
and leukocyte esterase and pyuria (>10 white blood cells μl-1; non-spun), noted on urinalysis.
Use of S. agalactiae cultured from the patient described in [12] was enacted according to the
principles of the Helsinki Declaration with approval from the UAB Institutional Review Board
(IRB) (X070722011) and the Human Ethics Committee (HEC) of Griffith University (MSC/
11/10/HREC). The UAB IRB and the Griffith University HEC waived the need for specific
informed consent. Bacteria were grown at 37˚C on Todd-Hewitt (TH) agar or in TH broth
(Thermo Fisher Scientific) agitated at 200 rpm for 16 h.
Mice and murine model of UTI
Three different groups of female C57BL/6 mice were used for this study; mice classed as
young (8–12 weeks of age), multiparous (Dam) mice (which have previously given birth to
litters), and aged mice (12 months of age). Aged mice were purchased from the Animal
Resource Centre (ARC; Perth, Australia) at 12 weeks of age and were housed at Griffith
University Animal Facilities for a further 9 months. Dam mice were purchased from ARC
as ex-breeder mice and were between 11–12 months of age. Urine was collected 24 h prior
to challenge and examined microscopically and by culture to exclude mice with a pre-exist-
ing condition, as described elsewhere [25]. Mice received food and water ad libitum and all
procedures were approved by the Griffith University Animal Ethics Committee (approval
number: MSC/03/12/AEC). The animals were monitored daily during the experimental
procedure. A protocol was used to define early/humane endpoints in cases where mice
might become severely ill prior to the experimental endpoint; this included escalated moni-
toring of mice based on clinical signs (locomotion, behaviour, appearance), which were
evaluated using a numerical score-sheet designed in consultation with a veterinarian to
determine when to euthanize the mice.
The murine model of UTI, utilizing female C57BL/6 mice and transurethral inoculation
was used, essentially as described elsewhere [11, 22]. Briefly, mice were challenged with 40–
50 μl of PBS containing 109 cfu of UPSA 0247 using a sterile Teflon coated catheter (0.28 mm
internal diameter, 0.61 mm outer diameter, 25 mm length; Terumo, Somerset, NJ) inserted
directly into the bladder. Control mice received sterile PBS. Methods used to alleviate suffer-
ing/distress included anesthesia during the challenge procedure (isoflurane, 3–4% atmo-
sphere), minimal handling and housing to include environmental enrichment. Urine was
collected at 24 and 48 h post infection (p.i.) and used for colony counts. Separate groups of
mice were euthanized at 24 and 48 h p.i. and the bladders were aseptically removed and pro-
cessed for colony counts or used for 23-target multiplex protein assays (BioPlex, BioRad). The
method of euthanasia was cervical dislocation. For multiplex protein assays, bladders were
homogenised in PBS containing cOmplete™ ULTRA protease inhibitor (Roche). Each experi-
ment used at least 8 mice per group and all experiments were performed twice, independently
over a period of 3 years.
Measurement of soluble inflammatory mediators
Bladder supernatants (50 μl) prepared from groups of PBS control and infected mice were
used to quantitate 23 cytokines in the tissue in response to infection. We used a mouse multi-
plex protein assay kit for these measurements (BioPlex, BioRad), which were performed
according to the manufacturers’ instructions.
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Statistical analyses
Colony count data derived from the analysis of bladders and urine were examined for normal-
ity using Shapiro-Wilk tests, and differences between groups were compared using Kruskal-
Wallis One-way Analysis of Variance (ANOVA) tests, followed by Dunn’s multiple compari-
son post-tests, with significance set at P< 0.05. Cytokine expression data were compared
using Kruskal-Wallis ANOVA, and specific pair-wise comparisons were performed using
Mann-Whitney U tests with significance set at P< 0.05. Group sizes and replicates in experi-
ments are indicated in each figure legend. All of the statistical analyses were performed using
GraphPad Prism version 6.0.
Results
Levels of S. agalactiae colonisation of bladder tissue are similar between
young and aged mice but bacteriuria levels differ markedly between
young, aged, and dam mice
To determine whether age and/or parity affects the ability of S. agalactiae to colonize the uri-
nary tract, young, aged, and dam mice were challenged with UPSA 0247 and bacterial titres
in the bladder and urine were examined at 24 h and 48 h p.i. We compared the numbers of
bacteria recovered from the bladders of young, aged, and dam mice at each time point, which
revealed significant decreases in the medians from 4.31, 4.27 and 4.39 at 24 h to 3.24, 2.86 and
2.62 log10 cfu 0.1g
-1 bladder at 48 h, respectively (Fig 1). There were no significant differences
in the bladder tissue bacterial burdens comparing the infected groups at 24 h and 48 h p.i.
There were no instances of animals dying prior to the experimental endpoint.
The numbers of S. agalactiae recovered from the urine of young mice were also significantly
different between all groups according to Kruskal-Wallis ANOVA tests. The median bacteri-
uria loads in aged mice (4.52 and 4.86 at 24 h and 48 h p.i., respectively), dam mice (3.15 and
2.48 at 24 h and 48 h p.i., respectively) and young mice (3.73 and 0 at 24 h and 48 h p.i, respec-
tively) did not significantly differ between the 24 h and 48 h time points (Fig 2). Strikingly, we
observed that aged mice exhibited significantly higher bacteriuria loads than young mice
(P< 0.01, P< 0.0001; Fig 2), and dam mice (P< 0.0001, P< 0.0001; Fig 2), at 24 h and 48 h
p.i., respectively. Thus, aged mice are significantly restricted in their ability to clear bacteriuria
due to S. agalactiae compared to young mice and dam mice, and multiparity is associated with
significantly better clearance of bacteriuria due to S. agalactiae compared to age-matched nul-
liparous mice.
We also analysed bacterial loads in the kidneys of mice and, consistent with published data
showing that colonisation occurs at a low frequency in C57BL/6 mice [26–28], we recovered
bacteria from the kidneys in 10% of the mice in each group (data not shown). Together,
these data establish that increased age, but not parity is associated with a higher bacteriuria
burden due to S. agalactiae but tissue bacterial loads are similar between young mice and aged
mice.
Cytokine production in the bladder following S. agalactiae UTI differs
between young and aged mice and changes over time
Analysis of cytokines identified major differences in the bladder immune response to infection
in young, aged, and multiparous backgrounds. Initial multiple comparisons revealed many sig-
nificant differences between and within groups, particularly for IL-1β, IL-12(p40), MCP-1, IL-
17 and others. We subsequently performed pairwise comparisons using Mann-Whitney U
tests to focus on comparisons of i) infected and control mice within a host background (i.e.
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Young, Aged, Dam), and ii) infected conditions across different host backgrounds. This analy-
sis revealed significantly higher levels of several cytokines in aged and young mice following
infection (compared to PBS controls) at 24 h p.i., including IL-6 and MIP-1β, which were not
significantly elevated in dam mice (Fig 3). We also identified differences between the responses
of young and aged mice to infection, including four markers that were significantly elevated in
young mice (IL-1β, IL-10, IL-13, eotaxin) but not aged or dam mice. In aged mice, five mark-
ers were significantly elevated following infection, but these were not significant in young
mice (IL-1α, IL-12(p40), IL-12(p70), MIP-1α, RANTES) (Fig 3). The levels of IL-3, IL-4, IL-9,
IL-10 and MIP-1β were significantly reduced in infected aged mice when directly compared to
infected young mice, and IL-12(p40), RANTES and G-CSF were increased (Fig 3). A synopsis
of the P values derived from multiple comparisons and pair-wise comparisons summarizing
the consistency in significance for several factors and discordance for some other cytokines
(i.e. P> 0.05 from multiple comparison tests vs. P< 0.05 from pair-wise comparisons), is
shown in S1 Fig.
At the 48 h time point we observed fewer significant responses to infection overall, with ele-
vations in the levels of IL-12(p40) in young mice, and KC and MCP-1 in aged mice (Fig 4)
Fig 1. Streptococcus agalactiae bacterial loads in the bladder in young, aged, and dam C57BL/6 mice at 24
and 48 h post-infection. Data are a combination (n = 21–32) of 3 separate experiments each with 8–12 mice. Bars
represent medians and are shown with interquartile ranges to illustrate the comparisons between groups based on
Kruskal-Wallis ANOVA tests, and Dunn’s multiple comparison post-tests, with significance levels indicated (*
P < 0.05; ** P < 0.01; ****P < 0.0001).
doi:10.1371/journal.pone.0167732.g001
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compared to their respective controls. There were no factors with significant differences
shared among aged and young mice at 48 h p.i. Consistent with the observations of infected
young and aged mice at 24 h p.i., there were significantly lower levels of IL-3 and IL-4, and
higher levels of IL-12(p40) and RANTES in infected aged mice at 48 h p.i. (Fig 4 and S1 Fig).
In addition to these, there were elevated levels of IL-12(p70) and reduced levels of KC, MCP-1,
and MIP-1α in the infected aged mice compared to the young group.
Multiparity alters the early bladder cytokine response to S. agalactiae
infection
Comparison of the immune response in multiparous dam mice and nulliparous aged mice
(age-matched at 11–12 months of age) at 24 h p.i. identified significantly higher levels of sev-
eral cytokines due to infection and dependent on the host background. For example, infected
dam mice exhibited higher levels IL-1α, IL-4, IL-12(p40), IL-17, G-CSF, KC, MCP-1, MIP-1α
and TNF-α compared to age-matched PBS-controls (Fig 3). There were also higher levels of
Fig 2. Streptococcus agalactiae bacterial loads in the urine in young, aged, and dam mice at 24 and 48 h
post-infection. Data are a combination (n = 29–42) of 3 separate experiments each with 8–12 mice. Bars
represent medians and are shown with interquartile ranges to illustrate the comparisons between groups based on
Kruskal-Wallis ANOVA tests, and Dunn’s multiple comparison post-tests, with significance levels indicated (*
P < 0.05; ** P < 0.01; ****P < 0.0001).
doi:10.1371/journal.pone.0167732.g002
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Fig 3. Streptococcus agalactiae UTI induces distinctive patterns of cytokine secretion in young, aged, and dam mice at 24 h post-infection. Pro-
inflammatory cytokines and growth factors (blue), chemokines (red) and regulatory cytokines (green) are highlighted using coloured axes. Median bars and
interquartile ranges are shown for 3 independent experiments combined (n = 6–13). The data were initially compared using Kruskal-Wallis ANOVA, and
Dunn’s multiple comparison post-tests. Additional pair-wise comparisons were performed using Mann-Whitney U tests to compare PBS and infected
conditions for cytokines across the same host background. Significance levels for the latter are indicated (* P < 0.05; ** P < 0.01; ***P < 0.001; ****
P < 0.0001). The figure denotes S. agalactiae as group B streptococcus (GBS).
doi:10.1371/journal.pone.0167732.g003
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Fig 4. Streptococcus agalactiae UTI induces distinctive patterns of cytokine secretion in young, aged, and dam mice at 48 h post-infection. Pro-
inflammatory cytokines and growth factors (blue), chemokines (red) and regulatory cytokines (green) are highlighted using coloured axes. Median bars and
interquartile ranges are shown for 3 independent experiments combined (n = 6–13). The data were initially compared using Kruskal-Wallis ANOVA, and
Dunn’s multiple comparison post-tests. Additional pair-wise comparisons were performed using Mann-Whitney U tests to compare PBS and infected
conditions for cytokines across the same host background. Significance levels for the latter are indicated (* P < 0.05; ** P < 0.01; ***P < 0.001; ****
P < 0.0001). The figure denotes S. agalactiae as group B streptococcus (GBS).
doi:10.1371/journal.pone.0167732.g004
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IL-5 in dam mice that were not significant in aged mice. Comparing infected dam mice and
infected aged mice at 24 h p.i. revealed only IL-3 as significantly elevated in the latter group.
There were significant differences in the levels of only a few factors between infected mul-
tiparous mice and PBS-control mice at 48 h p.i., including elevated levels of MCP-1, (consis-
tent with aged mice), IL-17 and IL-12 (p40). In comparing the response of infected aged and
infected dam mice, we observed significantly higher levels of IL-1β and IL-12(p40) in dam
mice (Fig 4).
Comparative immune responses to infection between mice groups and
time points
The immune responses that were consistent across all three infected mice groups at the early
(24 h) time point included IL-17, G-CSF, TNF-α, IL-4, KC and MCP-1 (S1 Fig [part C], Fig 3).
Thus, these factors are produced in response to infection in this model, independent of age
and parity. The responses that were consistent among aged mice and (age-matched) dam mice
(but not significant in young mice) included IL-1α, IL-12(p40) and MIP-1α. Cytokines that
were significantly elevated in nulliparous mice (young and aged) but not dam mice were IL-6
and MIP-1β (S1 Fig [part C], Fig 3). The cytokine profiles of infected young mice showed no
clear similarities between the 24 h and 48 h time points. In aged mice, KC and MCP-1 had ele-
vated levels at both 24 h and 48 h, the latter of which was also elevated in dam mice, together
with IL-17 and IL-12(p40) (S1 Fig [part C], Fig 3). Comparing the responses of infected young
mice to either aged or dam mice, identifies IL-3, IL-4, IL-9, IL-10 and MIP-1β as significantly
elevated in young mice, and RANTES, G-CSF, and IL-12(p40) as significantly elevated in the
aged mouse groups at 24 h (S1 Fig [part D], Fig 4). At 48 h, IL-3, IL-4 and IL-12(p70) are ele-
vated in young mice compared to either aged or dam mice, and IL12(p40), RANTES, MIP1α
and MCP-1 are elevated in the aged and dam mice compared to young (S1 Fig [part D]). Thus,
comparative profiling of bladder immune responses to S. agalactiae infection shows significant
effects of age and parity towards a number of well-described chemotactic, pro-inflammatory
and regulatory cytokines.
Discussion
Bacterial UTIs cause massive economic, societal and healthcare costs and are among the most
frequently occurring infections in humans. S. agalactiae has emerged in recent years as an
important gram-positive aetiological agent of UTI [7, 10]. During the past decade, while rates
of neonatal S. agalactiae disease have declined [29], the burden of S. agalactiae disease in
elderly adults has increased and UTIs are among the infections that are increasingly recog-
nized [7, 10]. The current study aimed to determine whether host background, in the context
of age and parity, might affect the pathogenesis of UTI, including the level of colonization of
and local immune response to S. agalactiae in experimentally-infected mice. One study that
examined differences between aged and young mice with S. agalactiae UTI [24] reported lower
bladder colonisation in aged mice vs. young mice, and higher colonisation with parity [24].
The results of the current study show (i) equivalent levels of bladder tissue colonisation in
young and aged mice, in contrast to prior findings [24], (ii) equivalent levels of bladder tissue
colonisation in young and dam mice, consistent with [24], (iii) increased age, but not parity
predisposes to higher bacteriuria burdens during S. agalactiae UTI, and (iv) both age and par-
ity effect the patterns of production of several regulatory and pro-inflammatory cytokines,
including KC, MCP-1, IL-17, MIP-1α and RANTES that are expressed during S. agalactiae
UTI in mice. Together, these findings provide essential novel insight into the significant role
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that host background, viz. age and parity, plays in determining the course of experimental UTI
due to this important human pathogen.
One of the most notable findings of the current study is the effect of increased age towards
the severity of S. agalactiae bacteriuria. Bacteriuria is a central aspect of UTI and can be impor-
tant in the context of ABU and persistent colonization of urine [15, 30, 31]; bacteriuria was not
studied in a prior report of S. agalactiae UTI in aged mice [24]. In a clinical context, studies
have shown higher prevalence rates of bacteriuria in elderly populations, as reviewed elsewhere
[18]. Unequal abilities of bacteria to grow in urine are known [32, 33], and were recently
reported for S. agalactiae [15]. Understanding the nature of bacteriuria for clinical applications
of novel therapeutic approaches, and to define the coevolution of hosts and bacteria, is emerg-
ing as a critical area [34–36]. Higher titre S. agalactiae bacteriuria in aged mice compared to
young mice, and an inability of aged mice to reduce bacteriuria in contrast to young mice pro-
vide evidence of heightened susceptibility to S. agalactiae bacteriuria with increasing age.
The increased susceptibility of elderly individuals to UTIs is a multifactorial process and is
thought to encompass weakening of the bladder muscles or other abnormal bladder function,
bladder outlet obstruction, increased use of long-term indwelling catheters, alterations in hor-
monal, metabolic and immune function, and increased use of various medications that may
impact UTI [3, 18, 37]. Other immune dysregulation, rather than impairment of immune sys-
tem function, has been associated with the effect of increased age towards impaired ability to
respond to and eradicate microbes [38]. The rates of eradication of UTI with any duration of
antibiotic therapy are lower in elderly adults compared to younger women [39], and there is
the emergent issue of overtreatment with antibiotics for suspected UTI in elderly adults that
leads to negative consequences such as multidrug-resistant organisms, as reviewed elsewhere
[40]. Thus, an improved understanding of the nature of heightened susceptibility to bacteriuria
in elderly adults, and S. agalactiae specifically, as observed in this study, is an important goal
for future studies. Recent findings of changes in metabolic characteristics and urine composi-
tion coincident with increasing age [41–44] suggest that comparisons of the ability of bacteria
to grow in urine from young and aged individuals might provide interesting insight into the
observed differences in bacteriuria noted in this study.
Due to the relationship between age and parity and UTI, we explored the effects of previous
pregnancy towards infection and immune responses to S. agalactiae UTI by studying dam,
age-matched nulliparous and young mice. A prior study reported on the susceptibility of mul-
tiparous mice to S. agalactiae single species UTI, polymicrobial UTI and ascending UTI due to
UPEC [24]. In the current study dam mice exhibited equivalent bacteriuria compared to
young mice but less bacteriuria than age-matched nulliparous mice. The effects of parity on
UTI may differ for distinct uropathogens and mixed infections; however, the seemingly para-
doxical new finding that, even though human pregnancy is associated with higher UTI risk,
dam mice had less bacteriuria, suggests that parity somehow aids in controlling S. agalactiae
bacteriuria. There is scant literature on urinary composition related to post-pregnancy that
may explain this finding. It is possible that different urinary compositions between dam and
age-matched nulliparous mice may affect bacterial growth in urine or other aspects of the
host-pathogen interactions in the bladder. In one prior study, alterations in hormonal condi-
tions and urinary tract anatomy was linked to the disproportionally high rates of UTIs among
pregnant women [18]. In ovariectomized mice, which have been used as a model to study UTI
in menopausal women, pathogenesis is subject to effects that are related to estrogen availabil-
ity. Together, these observations highlight the important role that hormonal conditions might
play in determining bladder health and pathogen defense [45]. The disparities observed in bac-
teriuria between age-matched dam and nulliparous mice in the current study are thus of
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interest for future studies of any potential effects of urinary composition and/or hormonal
changes in this model.
Comparing immune responses of young and aged mice to S. agalactiae UTI shows that
aged mice produce several cytokines in the bladder in a similar fashion to young mice at 24 h
following infection. In contrast, aged mice produce more IL-12(p40), G-CSF and RANTES
than young mice, and less IL-3, IL-9, IL-4, IL-10 and MIP-1β. The observations of elevated lev-
els of G-CSF and RANTES in aged mice in the current study support prior reports that have
shown increased levels of other chemokines in aged populations [46–48]. The current study
also identifies several factors, including IL-1α, MIP-1α, RANTES, IL-12(p40) and IL-12(p70)
that are induced in aged mice but not young mice following infection (compared to PBS) and
other factors, including IL-1β, IL-10, IL-13 and eotaxin that are specific to young mice. The
observations of elevated levels of IL-1β in young mice in the current study are consistent with
a prior report that showed younger adults produced higher levels of IL-1β compared to elderly
individuals [46]. However, in contrast to prior studies that report high levels of IL-6 in elderly
adults compared to younger adults [46, 49, 50], we failed to detect a statistically significant dif-
ference in the levels of IL-6 between young mice and aged mice in the current study (medians:
young 95 pg/mL vs. aged 572 pg/mL, P = 0.11; Fig 3). Taken together, the observations of the
current study pin-point several cytokine responses that are consistent with prior literature and
other responses that are unique to our study. Finally, the cytokine responses observed in the
bladders of mice at 24 h subsided by 48 h, at which time, and in a similar way to the observa-
tions of cytokine responses in young and aged mice, there were few factors showing differen-
tial levels between infected and PBS control mice.
It is important to consider the observations of cytokine responses in the current study in
the context of an expansive literature on “immune system aging” and the changes that occur in
the immune system with increased age, termed immunosenescence [51, 52]. The literature
offers insight into the wide-ranging changes in cytokine production that can occur with
increased age and the complexity and nuances that can be associated with such changes.
Importantly, the impracticality of generalizing cytokine responses during immunosenescence
reflects (i) distinct effects in the innate and adaptive arms of the immune response [52], (ii)
dissimilarities between cell types and immune system compartments [51], (iii) unique study
designs that include species-specific differences, and potential assay artefacts such as plastic-
ware effects [53], and (iv) animal models that are limited in translational capacity to human
biology [54]. Collectively, these issues can constrain comparisons of individual studies and
warrant an avoidance of endeavouring to oversimplify the cytokine data in the current study.
Adding to the aforementioned complexity of the literature on immunosenescence are con-
flicting reports on the effects of increased age towards cytokine responses in young and aged
cells. For example, one study reported increased levels of pro-inflammatory cytokines, includ-
ing IL-6 and TNF-α in some types of aged cells (e.g. B cells and dendritic cells), and plasma, as
reviewed elsewhere [55]. These findings are consistent with changes in the T cell compartment
during aging that include increased expression of pro-inflammatory cytokines and IL-6 [51].
In contrast, another study reported no difference in pro-inflammatory cytokine secretion
between young and aged cells, including in dendritic cells [56]. In addition, studies of rodents
have reported a decline in pro-inflammatory cytokine production, including for IL-6 and
TNF-α with aging [52]. Apparent contradictions such as these should be viewed in the context
of the broader immunosenescence literature, as discussed above, and, in particular, the
changes in cytokine expression that can be cell type-dependent, such as for effector lympho-
cytes [51], and affected by study design. Finally, to what extent differences in the degrees and
patterns of cytokine production between young and aged conditions are influenced by the
type of microbial challenge or species differences, remains unclear.
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It is of note that we measured cytokine levels in bladder tissue from mice but we did
not measure cytokines in urine in the current study, which would be of interest given our
finding that increased age predisposes mice to a higher burden of S. agalactiae bacteriuria.
Future studies to examine cellular changes in response to infection, including inflamma-
tory infiltrates in the bladder and neutrophil levels in urine sediments would also provide
a more complete picture of cytokine release and cytological responses in this model. It is
noteworthy that the type of innate immune response that occurs during S. agalactiae UTI
is pathogen-specific [12]; and it would thus be of interest to investigate the effects of age
and parity on UTI caused by other bacterial uropathogens to explore potential differences
in innate immune responses triggered by distinct pathogens. It is also noteworthy that we
used a S. agalactiae strain originally isolated from a case of uncomplicated acute cystitis
[12]. Differences in the early steps in pathogenesis of S. agalactiae UTI have been reported
related to strain differences [14]; some of these differences may relate to virulence factors
such as the hemolysin [14, 57], or capsule, the sialic acids of which enhance the survival
of S. agalactiae in the urinary tract [13] and augment the ability of E. coli to survive in the
bladder [21]. The inoculum dose also affects bladder colonization in mice, according to
escalating challenge dose studies [12]. Differences such as these may account for distinct
observations related to the effects of age towards bladder colonization in mice in the cur-
rent study, where no difference was detected in contrast to a previous study [24]. The
overall prevalence of positive kidney cultures detected in the current study is also low
compared to [24] but is largely consistent with prior reports of low rates of kidney coloni-
sation following a single transurethral challenge in C57BL/6 mice [26, 27].
In summary, this study shows that the host environment plays an important role in influ-
encing the severity of UTI due to S. agalactiae; infection dynamics, particularly in the context
of bacteriuria, depend on age and parity, which also affect the nature of innate immune
responses to infection. We conclude that UTI due to S. agalactiae in young, aged, and dam
mice involves equivalent levels of bladder tissue colonisation in young, aged, and dam mice,
but higher bacteriuria is associated with increased age but not parity. Both age and parity effect
the expression of several key regulatory and pro-inflammatory cytokines and this may play a
role in shaping the pathogenesis of these infections in different host backgrounds.
Supporting Information
S1 Fig. Comparative analysis of bladder immune responses of young, aged, and dam mice
following S. agalactiae infection. Cytokine levels were initially compared using Kruskal-Wal-
lis ANOVA and Dunn’s multiple comparison post-tests (A and B), followed by pair-wise com-
parisons of specific cytokines within host background groups across treatments (PBS control
vs. infected) using Mann-Whitney U tests (C and D) with significance set at P< 0.05. Cyto-
kines that showed significantly elevated levels in infected young, aged, or dam mice, compared
to their respective PBS-mock infection controls, at 24 h and 48 h p.i., are highlighted with grey
squares (A and C). Cytokines that showed significantly different levels between infected young
and aged, young and dam, or dam and aged mice are also shown, with filled coloured squares
indicating higher cytokine responses (B and D). Consistent responses between the 24 h and 48
h p.i time points are indicated with stars.
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